Condition
Malignant Mesothelioma
Estimated Enrollment: 30
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Primary Purpose: Treatment
Study ID Numbers: CDR0000066141|P30CA016087|NYU-9850|MDA-FDR001234|MDA-ID-95209|NCI-G99-1575
Study First Received: December 10, 1999
Last Updated: March 25, 2011
Estimated Primary Completion Date: May 2001
Primary Outcome Measures:
Sponsors and Collaborators:
New York University School of Medicine|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00004033
